Ping An Insurance Company of China, Ltd. (HKEx: 2318; SSE: 601318) announced over the weekend that the Ping An Global Voyager Fund has invested in AI medical solution company Airdoc during its B+ round of funding. Ping An reported it has led the round along with CITIC) and the investment aims to boost application of AI healthtech.
According to Ping An, Airdoc is described as a high-tech company that is dedicated to improving the efficiency of medical services through artificial intelligence. It develops deep learning techniques based on massive data labeled by medical experts and provides intelligent services to assist doctors and benefit patients. Speaking about the investment, Jonathan Larsen, Chief Innovation Office of Ping An Group, Chairman and CEO of Ping An Global Voyager Fund, stated:
“This is an important investment for Ping An and the Global Voyager Fund. Airdoc brings world class AI-driven medical imaging analytical capabilities in multiple domain areas. There are many applications for their solutions within the Ping An health and financial services ecosystem, in China, regionally and internationally. We are excited to be working with such a high quality team both as an investor and a strategic partner.”
Dr. Marco Huesch, managing director and Chief Medical Officer Ping An Global Voyager Fund, went on to add:
“We are excited to partner with Airdoc and proud to co-lead the firm’s Series B+ round. Airdoc’s market leading medical AI retinal imaging technology offers consumers a fast, convenient and accurate screening service for more than two dozen important diseases, all available at multiple, retail check-up center locations in China.”